Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-01-10

Clinical Trial Update: Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluates epoetin alfa or epoetin beta, with or without iron infusion, for treating anemia in cancer patients. The trial status is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPOETIN ALFA (EPOETIN ALFA)
  • epoetin beta (epoetin beta)

Snippet

Sponsor: St. Bartholomew's Hospital | Conditions: Anemia, Leukemia | Phase 3 | Status: UNKNOWN